SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001395064-22-000085
Filing Date
2022-05-31
Accepted
2022-05-31 06:14:56
Documents
20
Period of Report
2022-05-31

Document Format Files

Seq Description Document Type Size
1 FORM 6-K form6k-3_053122.htm 6-K 12053
2 EX-99.1 shareholder_letter.htm EX-99.1 51116
3 GRAPHIC shareholder_letter001.jpg GRAPHIC 170721
4 GRAPHIC shareholder_letter002.jpg GRAPHIC 202431
5 GRAPHIC shareholder_letter003.jpg GRAPHIC 217360
6 GRAPHIC shareholder_letter004.jpg GRAPHIC 205795
7 GRAPHIC shareholder_letter005.jpg GRAPHIC 187475
8 GRAPHIC shareholder_letter006.jpg GRAPHIC 224652
9 GRAPHIC shareholder_letter007.jpg GRAPHIC 187885
10 GRAPHIC shareholder_letter008.jpg GRAPHIC 180354
11 GRAPHIC shareholder_letter009.jpg GRAPHIC 121158
12 GRAPHIC shareholder_letter010.jpg GRAPHIC 189674
13 GRAPHIC shareholder_letter011.jpg GRAPHIC 216109
14 GRAPHIC shareholder_letter012.jpg GRAPHIC 180456
15 GRAPHIC shareholder_letter013.jpg GRAPHIC 203783
16 GRAPHIC shareholder_letter014.jpg GRAPHIC 209074
17 GRAPHIC shareholder_letter015.jpg GRAPHIC 207071
18 GRAPHIC shareholder_letter016.jpg GRAPHIC 202368
19 GRAPHIC shareholder_letter017.jpg GRAPHIC 217661
20 GRAPHIC shareholder_letter018.jpg GRAPHIC 150693
  Complete submission text file 0001395064-22-000085.txt   4851739
Mailing Address 1-1, NIHONBASHI-HONCHO 2-CHOME, CHUO-KU TOKYO M0 103-8668
Business Address 1-1, NIHONBASHI-HONCHO 2-CHOME, CHUO-KU TOKYO M0 103-8668 81332782111
TAKEDA PHARMACEUTICAL CO LTD (Filer) CIK: 0001395064 (see all company filings)

IRS No.: 000000000
Type: 6-K | Act: 34 | File No.: 001-38757 | Film No.: 22980317
SIC: 2834 Pharmaceutical Preparations